The deal is a non-exclusive agreement and the companies were selected through an international bidding process. The arrangement includes the transfer of technology dealing with the manufacture, testing, packaging, storage and handling of the drug's active ingredient. The drug is a second line antiretroviral for patients who have developed a resistance to more common drugs. Peter Dolan, the chief executive of BMS, said the company has taken a broad-based approach to addressing the Aids crisis, which included providing Aids medicines at no-profit prices.
South African and Indian firms win aids drug license
Aspen Pharmacare, South Africa, and Emcure Pharmaceuticals, India, have won a royalty-free licence agreement for the generic of Bristol-Myers Squibb's (BMS) antiretroviral drug Atazanavir, which earned BMS $696 million in sales in the US last year. Atazanavir is known as Reyataz in the US.
May 31, 2007
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Researched List: Engineering Services Firms
Looking for engineering services? Our curated list features 100+ companies specializing in civil, process, structural, and electrical engineering. Many also offer construction, design, and architecture services. Download to access company names, markets served, key services, contact information, and more!
Download Now
Downloads
